Author Correction: COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials

被引：0

作者：

Aakash Desai

Justin F. Gainor

Aparna Hegde

Alison M. Schram

Giuseppe Curigliano

Sumanta Pal

Stephen V. Liu

Balazs Halmos

Roman Groisberg

Enrique Grande

Tomislav Dragovich

Marc Matrana

Neeraj Agarwal

Sant Chawla

Shumei Kato

Gilberto Morgan

Pashtoon M. Kasi

Benjamin Solomon

Herbert H. Loong

Haeseong Park

Toni K. Choueiri

Ishwaria M. Subbiah

Naveen Pemmaraju

Vivek Subbiah

机构：

[1] Mayo Clinic College of Medicine,Division of Medical Oncology

[2] Massachusetts General Hospital,Department of Medicine

[3] University of Alabama at Birmingham,Department of Hematology and Oncology, O’Neal Comprehensive Cancer Center

[4] Memorial Sloan Kettering Cancer Center,Department of Oncology and Hemato

[5] University of Milan and European Institute of Oncology, Oncology

[6] IRCCS,Department of Medical Oncology

[7] City of Hope Comprehensive Cancer Center,Department of Developmental Therapeutics, Lombardi Comprehensive Cancer Center

[8] Georgetown University,Department of Oncology, Montefiore Medical Center

[9] Albert Einstein College of Medicine,Department of Melanoma/Sarcoma Medical Oncology

[10] Rutgers Cancer Institute of New Jersey,Department of Medical Oncology

[11] MD Anderson Cancer Center Madrid,Department of Hematology/Oncology

[12] MD Anderson Banner Cancer Center,Precision Cancer Therapies (Phase I) Research Program, Experimental Therapeutics

[13] Ochsner,Division of Oncology, Department of Medicine, Huntsman Cancer Institute

[14] University of Utah,Center for Personalized Cancer Therapy, Moores Cancer Center

[15] Sarcoma Oncology Center,Department of Oncology

[16] University of California San Diego,Division of Hematology, Oncology and Blood and Marrow Transplantation, Department of Medicine

[17] Skåne University Hospital,Department of Medical Oncology

[18] University of Iowa,Department of Clinical Oncology, State Key Laboratory of Translational Oncology

[19] Peter MacCallum Cancer Centre,Division of Oncology, Department of Medicine

[20] Melbourne,Department of Medical Oncology

[21] The Chinese University of Hong Kong,Department of Palliative, Rehabilitation & Integrative Medicine, Division of Cancer Medicine

[22] Washington University in St. Louis,Department of Leukemia, Division of Cancer Medicine

[23] Dana- Farber Cancer Institute,Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), Division of Cancer Medicine

[24] University of Texas MD Anderson Cancer Center,Division of Pediatrics

[25] University of Texas MD Anderson Cancer Center,MD Anderson Cancer Network

[26] University of Texas MD Anderson Cancer Center,undefined

[27] The University of Texas MD Anderson Cancer Center,undefined

[28] The University of Texas MD Anderson Cancer Center,undefined

来源：

Nature Reviews Clinical Oncology | 2021年 / 18卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

A Correction to this paper has been published: https://doi.org/10.1038/s41571-021-00503-2.

引用

页码：320 / 320

共 50 条

[21] Author Correction: Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England
Gayatri Amirthalingam
Jamie Lopez Bernal
Nick J. Andrews
Heather Whitaker
Charlotte Gower
Julia Stowe
Elise Tessier
Sathyavani Subbarao
Georgina Ireland
Frances Baawuah
Ezra Linley
Lenesha Warrener
Michelle O’Brien
Corinne Whillock
Paul Moss
Shamez N. Ladhani
Kevin E. Brown
Mary E. Ramsay
Nature Communications, 13
[22] Examining reporting and representation of patients with cancer in COVID-19 clinical trials
Rabow, Maya
Wang, Christine
Zhang, Sylvia
Tahir, Peggy Mary
Small, Eric J.
Borno, Hala T.
CANCER REPORTS, 2021, 4 (04)
[23] COVID-19 in subjects at risk participating in clinical trials during the pandemic in Argentina
Ibelli, Fabiana B.
Bozzo, Raul
Iannantuono, Maria Victoria
Molina, Maria Emilia
Pederoda, Julieta
Iannantuono, Ruben
MEDICINA-BUENOS AIRES, 2023, 83 (05) : 683 - 691
[24] COVID-19 Vaccine response in cancer patients
Segelov, Eva
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 107 - 108
[25] Clinical outcomes in patients with COVID-19 and gynecologic cancer: A society of gynecologic oncology COVID-19 and gynecologic cancer registry study
Glaser, Gretchen E.
Lara, Olivia D.
Pothuri, Bhavana
Grimaldi, Carolina Gomez
Prescott, Lauren S.
Mastroyannis, Spyridon A.
Kim, Sarah
ElNaggar, Adam C.
Torres, Diogo
Conrad, Lesley B.
McGree, Michaela
Weaver, Amy
Huh, Warner K.
Cohn, David E.
Yamada, S. Diane
Fader, Amanda N.
GYNECOLOGIC ONCOLOGY, 2022, 167 (02) : 146 - 151
[26] COVID-19 vaccine trials in Africa
Makoni, Munyaradzi
LANCET RESPIRATORY MEDICINE, 2020, 8 (11): : E79 - E80
[27] COVID-19 pandemic slows launch of oncology clinical trials.
Lamont, Elizabeth B.
Diamond, Sheila S.
Katriel, Ron G.
Lui, Jingshu
Ensign, Lisa
Alexander, Caleb
CLINICAL CANCER RESEARCH, 2020, 26 (18)
[28] Effectively Conducting Oncology Clinical Trials During the COVID-19 Pandemic
Yeboa, Debra Nana
Akinfenwa, Chidinma Anakwenze
Nguyen, Jonathan
Amaya, Diana
de Gracia, Beth
Ning, Matthew
Cox, Victoria
De, Brian
Smith, Benjamin D.
Lin, Lili
Beddar, Sam
Hoang, Hanh
Koong, Albert
Liao, Zhongxing
ADVANCES IN RADIATION ONCOLOGY, 2021, 6 (03)
[29] Reporting of health equity considerations in vaccine trials for COVID-19: author's reply
Kou, Roger
Mbuagbaw, Lawrence
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2024, 171
[30] Oncology clinical trials in the time of COVID-19: how a pandemic can revolutionize patients' care
Massari, Francesco
Mollica, Veronica
Salvagni, Stefania
Tognetto, Michele
Ardizzoni, Andrea
FUTURE ONCOLOGY, 2020, 16 (20) : 1413 - 1416

← 1 2 3 4 5 →